查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2166714

心房分流裝置市場：全球市場預測，2026-2032年

Interatrial Shunt Device Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心房分流裝置市場將成長至 3.4532 億美元，複合年成長率為 8.81%。

主要市場統計數據
基準年 2025 1.9121億美元
預計年份：2026年 2.0828億美元
預測年份 2032 3.4532億美元
複合年成長率 (%) 8.81%

心房分流裝置：執行摘要

心房分流裝置旨在建立可控的心臟室通路，主要用於治療與心臟衰竭及相關血流動力學紊亂相關的左心房壓力升高。該領域的發展受到許多因素的影響，包括未滿足的臨床需求、手術安全性、患者選擇、循證醫學證據的獲取、保險報銷以及將導管介入治療整合到結構化的心臟治療方案中。這些裝置的廣泛應用取決於其能否證明具有永續的生理獲益，以及可接受的植入風險和切實可行的追蹤要求。

臨床和程序方面的變革將重塑這一領域

對於儘管接受了基於指南的藥物治療，症狀仍然持續存在的患者，該領域的發展趨勢正轉向微創、生理學導向的治療方法。這項進展得益於植入裝置設計、輸送系統、影像技術和病患選擇方案的改進。臨床研發也正從驗證技術可行性轉向提供證據，證明降低血壓與運動能力、生活品質、住院負擔和功能狀態等重要結果有關。長期耐用性、設備通暢性、血栓症管理以及與未來心臟介入治療的相互作用仍然是重要的考慮因素。

利用人工智慧 (AI) 加強甄選、監測和證據生成

人工智慧 (AI) 可透過改進心臟超音波圖、心臟影像、血流動力學記錄和縱向臨床數據的解讀，為心房分流術提供支援。預測模型有助於識別最有可能獲益的患者，區分壓迫引起的充血和其他症狀性原因，並突顯與手術和追蹤相關的風險。 AI 驅動的監測還可以透過結合症狀、穿戴式裝置訊號和遠端檢測數據，支持早期介入。然而，臨床上有效的應用需要具有代表性的資料集、透明的檢驗、網路安全措施、臨床醫生監督，以及演算法建議能夠提高醫療品質而非使工作流程複雜化的證據。

區域性見解：實施取決於基礎設施和獲得結構性心臟病治療的機會。

北美擁有完善的心臟基礎設施、活躍的臨床研究以及相對廣泛的專業導管介入治療，但保險公司強制規定的證據要求仍有重要影響。歐洲擁有先進的心臟中心，但各國的健保報銷方案和法律規範存在區域差異。亞太地區臨床需求龐大，介入治療能力也不斷提升，但成熟的都市區醫療體系與服務不足的地區在醫療資源取得上有顯著差距。拉丁美洲的特點是專科醫師資源分佈不均、公私資金籌措投入存在差異，以及需要建立可擴展的轉診和追蹤模式。中東正在發展專業的心血管中心，其建設取決於對醫療體系的投資以及進口技術的取得。非洲在先進影像技術、導管介入治療能力、訓練有素的人員以及醫療服務的連續性方面面臨更大的限制，因此建立夥伴關係、開展培訓以及合理篩選患者尤為重要。

群體特定洞察：經濟特區和聯盟推動採用

東協市場在監管成熟度、專業能力和醫療資金來源方面差異顯著，因此需要區域培訓網路和靈活的准入策略。金磚國家擁有大規模的病患群體，但其國內醫療設備研發能力、報銷體系和臨床基礎設施水準各不相同，本地證據和生產夥伴關係會影響醫療器材的採納。歐盟受惠於跨境科學合作，但仍需妥善管理國家支付體系和醫院採納流程。七國集團（G7）的醫療體系通常在研發能力和操作技能方面表現出色，但可能面臨療效、安全性和預算影響方面的嚴格審查。海灣合作理事會（GCC）國家可以利用集中化的專家網路和對三級醫療的投資，但轉診協調仍然至關重要。北約成員國的醫療體系各不相同，可以透過通用的臨床標準和人力資源發展來提高醫療體系的一致性，而無需預設統一的准入條件。

各國具體情況：監管、臨床和准入的優先事項各不相同

澳洲和加拿大擁有卓越的循環系統中心，但由於人口分佈分散，轉診途徑和遠端追蹤至關重要。巴西和墨西哥必須注意公立和私立醫療資源取得的差異以及專科醫生的集中程度。中國和印度正在擴大介入治療能力，但醫院容量、實證要求和財政能力方面存在顯著的區域差異。日本、韓國、新加坡和澳洲擁有強大的、技術導向的臨床生態系統，其中日本尤其強調基於嚴謹證據的標準化流程。法國、德國、義大利、西班牙和英國已建立循環系統網路​​，但報銷、啟動和推廣流程因系統而異。俄羅斯的醫療保健服務取得環境受到醫療系統限制、監管條件和專用設備可用性的影響。美國在結構性心臟病領域擁有豐富的專業知識和臨床研究活動，保險覆蓋範圍、編碼和比較證據是啟動治療的關鍵。

心房分流裝置產業領導者可採取的優先事項

領導者首先應著重製定明確的患者選擇標準，並以有創和非侵入性血流動力學證據為支撐。臨床項目應規範影像檢查、植入、抗血栓治療、出院計畫和長期後續觀察。實證策略應衡量以病人為中心的療效、持久性、安全性和資源利用率，而非僅依賴技術上的成功。市場准入計畫應依各國的健保報銷方案進行調整，並輔以適用於各方案的衛生經濟學分析。與心臟衰竭專家、介入性心臟病專家、影像團隊、保險公司和患者團體開展合作將有助於該設備的推廣應用。最後，各機構應建構可互通的資料系統，並透過前瞻性檢驗、偏差監測、隱私權保護和明確的臨床醫師課責，妥善管理人工智慧的使用。

有助於決策的高階主管觀點調查方法

本執行摘要以提供的市場定義（心房分流裝置）為基礎，從臨床需求、技術發展、醫療服務、監管、報銷和區域循環系統。全面的調查計畫將透過交叉引用同儕審查的臨床文獻、臨床試驗註冊資訊、監管文件、報銷文件、醫院層面的專業知識、醫療專業人員訪談和病患結局數據，來區分已確立的證據和新興的假設。

結論：證據品質是決定是否繼續採用此技術的關鍵因素。

儘管心房分流裝置能夠有效應對壓力相關性心臟病的許多挑戰，但其持續應用不僅取決於手術可行性。最有效的推廣途徑應結合嚴格的患者篩選、成功的植入、長期的安全監測、顯著的患者療效以及與當地支付和醫療服務系統的兼容性。鑑於區域差異，靈活的培訓、轉診和追蹤模式至關重要。人工智慧若能得到負責任的檢驗，可以增強這些環節，但臨床判斷和透明的證據仍必須佔據核心地位。優先考慮療效、互通性和公平推廣的行業領導者將更有能力支持其負責任地融入現代心臟衰竭治療系統。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 心房分流裝置市場：依產品類型分類

  • 永恆的
  • 可恢復類型

第8章：心房分流裝置市場：依適應症分類

  • 射血分數保留的心臟衰竭
  • 射血分數降低的心臟衰竭

第9章 心房分流裝置市場：依手術類型分類

  • 外科
  • 經導管

第10章 心房分流裝置市場：依病患年齡層別分類

  • 成人
  • 老年人
  • 兒童

第11章 心房分流裝置市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第12章 心房分流裝置市場：依通路分類

  • 直接競標
  • 銷售代理
    • 全國銷售代理
    • 區域銷售代理
  • 電子商務

第13章 心房分流裝置市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 心房分流裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 心房分流裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cardiatis SA
  • Corvia Medical, Inc.
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Occlutech International AB
  • Terumo Corporation
  • V-Wave Ltd.
  • WL Gore & Associates, Inc.

第18章 主要專家

Product Code: MRR-1F6B55428621

The Interatrial Shunt Device Market is projected to grow by USD 345.32 million at a CAGR of 8.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 191.21 million
Estimated Year [2026] USD 208.28 million
Forecast Year [2032] USD 345.32 million
CAGR (%) 8.81%

Interatrial Shunt Devices: Executive Summary

Interatrial shunt devices are designed to create a controlled communication between the atria, primarily to manage elevated left atrial pressure associated with heart failure and related hemodynamic disorders. The field is shaped by unmet clinical needs, procedural safety, patient selection, evidence generation, reimbursement, and the integration of catheter-based therapies into structural-heart programs. Adoption depends on demonstrating durable physiological benefit alongside acceptable implantation risk and practical follow-up requirements.

Clinical and Procedural Shifts Reshaping the Field

The landscape is moving toward minimally invasive, physiology-guided treatment for patients who remain symptomatic despite guideline-directed medical therapy. Progress is being influenced by improvements in implant design, delivery systems, imaging, and patient-selection protocols. Clinical development is also shifting from proof of technical feasibility toward evidence that links pressure reduction with meaningful outcomes such as exercise capacity, quality of life, hospitalization burden, and functional status. Long-term durability, device patency, thrombosis management, and interaction with future cardiac interventions remain important considerations.

Artificial Intelligence Strengthens Selection, Monitoring, and Evidence Generation

Artificial intelligence can support interatrial shunt programs by improving interpretation of echocardiography, cardiac imaging, hemodynamic recordings, and longitudinal clinical data. Predictive models may help identify patients most likely to benefit, distinguish pressure-driven congestion from alternative causes of symptoms, and flag procedural or follow-up risks. AI-enabled monitoring could also combine symptoms, wearable signals, and remote measurements to support earlier intervention. However, clinically useful deployment requires representative datasets, transparent validation, cybersecurity controls, clinician oversight, and evidence that algorithmic recommendations improve care rather than add workflow complexity.

Regional Insights: Adoption Depends on Structural-Heart Capacity and Access

North America is characterized by advanced structural-heart infrastructure, active clinical research, and comparatively broad access to specialized catheter-based procedures, while payer evidence requirements remain influential. Europe combines sophisticated cardiac centers with varied national reimbursement and regulatory pathways across the region. Asia-Pacific presents substantial clinical need and expanding interventional capabilities, but access differs widely between mature urban systems and underserved areas. Latin America is shaped by uneven specialist availability, public-private financing differences, and the need for scalable referral and follow-up models. The Middle East is developing specialized cardiovascular hubs, with adoption influenced by health-system investment and imported technology access. Africa faces greater constraints in advanced imaging, catheterization capacity, trained personnel, and continuity of care, making partnerships, training, and appropriate patient selection especially important.

Group Insights: Economic Blocs and Alliances Shape Implementation

ASEAN markets differ substantially in regulatory maturity, specialist capacity, and healthcare financing, favoring regional training networks and adaptable access strategies. BRICS members combine large patient populations with varied levels of domestic device capability, reimbursement, and clinical infrastructure; local evidence and manufacturing partnerships may influence implementation. The European Union benefits from cross-border scientific collaboration but still requires navigation of national payment and hospital-adoption processes. G7 systems generally have strong research and procedural capabilities, while scrutiny of comparative effectiveness, safety, and budget impact can be high. GCC countries can leverage concentrated specialist networks and investment in tertiary care, although referral coordination remains important. NATO members span diverse health systems, so shared clinical standards and workforce development may improve consistency without assuming uniform access.

Country Insights: Diverse Regulatory, Clinical, and Access Priorities

Australia and Canada combine capable cardiovascular centers with geographically dispersed populations, making referral pathways and remote follow-up relevant. Brazil and Mexico require attention to public-private access differences and specialist concentration. China and India offer expanding interventional capacity but substantial regional variation in hospital capability, evidence requirements, and affordability. Japan, South Korea, Singapore, and Australia have strong technology-oriented clinical ecosystems, with Japan emphasizing careful evidence and procedural standardization. France, Germany, Italy, Spain, and the United Kingdom possess established cardiology networks, yet reimbursement, commissioning, and adoption processes differ by system. Russia's access environment is influenced by healthcare-system constraints, regulatory conditions, and availability of specialized devices. The United States has extensive structural-heart expertise and clinical research activity, with coverage, coding, and comparative evidence central to implementation.

Actionable Priorities for Interatrial Shunt Device Leaders

Leaders should focus first on clearly defined patient-selection criteria supported by invasive and noninvasive hemodynamic evidence. Clinical programs should standardize imaging, implantation, antithrombotic management, discharge planning, and longitudinal surveillance. Evidence strategies should measure patient-centered outcomes, durability, safety, and resource utilization rather than relying only on technical success. Market access plans should be tailored to national reimbursement structures and supported by health-economic analyses appropriate to each system. Partnerships with heart-failure specialists, interventional cardiologists, imaging teams, payers, and patient organizations can strengthen adoption. Finally, organizations should build interoperable data systems and govern AI use through prospective validation, bias monitoring, privacy protection, and clear clinician accountability.

Research Methodology for a Decision-Useful Executive View

This executive summary uses the supplied market definition-interatrial shunt devices-and organizes interpretation around clinical need, technology development, care delivery, regulation, reimbursement, and regional implementation conditions. Insights are framed qualitatively and avoid unsupported market estimates, shares, forecasts, or company-specific claims. Regional, group, and country observations reflect differences in healthcare infrastructure, cardiovascular specialization, evidence expectations, and access pathways. A full research program would triangulate peer-reviewed clinical literature, trial registries, regulatory publications, reimbursement documents, hospital-level expertise, practitioner interviews, and patient-outcome data, while separating established evidence from emerging hypotheses.

Conclusion: Evidence Quality Will Determine Sustainable Adoption

Interatrial shunt devices address an important challenge in pressure-related cardiac disease, but durable adoption will depend on more than procedural feasibility. The strongest pathways will combine rigorous patient selection, reliable implantation, long-term safety surveillance, meaningful patient outcomes, and alignment with local payment and delivery systems. Regional disparities make adaptable training, referral, and follow-up models essential. Artificial intelligence can enhance these activities when validated responsibly, but clinical judgment and transparent evidence must remain central. Industry leaders that prioritize outcomes, interoperability, and equitable implementation will be better positioned to support responsible integration into contemporary heart-failure care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Interatrial Shunt Device Market, by Product Type

  • 7.1. Introduction
  • 7.2. Permanent
  • 7.3. Retrievable

8. Interatrial Shunt Device Market, by Indication

  • 8.1. Introduction
  • 8.2. Heart Failure With Preserved Ejection Fraction
  • 8.3. Heart Failure With Reduced Ejection Fraction

9. Interatrial Shunt Device Market, by Procedure Type

  • 9.1. Introduction
  • 9.2. Surgical
  • 9.3. Transcatheter

10. Interatrial Shunt Device Market, by Patient Age Group

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Geriatric
  • 10.4. Pediatric

11. Interatrial Shunt Device Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Cardiac Centers
  • 11.4. Hospitals

12. Interatrial Shunt Device Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Direct Tender
  • 12.3. Distributor
    • 12.3.1. National Distributor
    • 12.3.2. Regional Distributor
  • 12.4. E-Commerce

13. Interatrial Shunt Device Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Interatrial Shunt Device Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Interatrial Shunt Device Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Boston Scientific Corporation
  • 17.3. Cardiatis SA
  • 17.4. Corvia Medical, Inc.
  • 17.5. Edwards Lifesciences Corporation
  • 17.6. Medtronic plc
  • 17.7. Occlutech International AB
  • 17.8. Terumo Corporation
  • 17.9. V-Wave Ltd.
  • 17.10. W. L. Gore & Associates, Inc.

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Interatrial Shunt Device Market, Years Considered for the Study
  • FIGURE 2. Global Interatrial Shunt Device Market, Research Design
  • FIGURE 3. Global Interatrial Shunt Device Market, Research Framework
  • FIGURE 4. Global Interatrial Shunt Device Market, Data Triangulation
  • FIGURE 5. Global Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Interatrial Shunt Device Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Interatrial Shunt Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Interatrial Shunt Device Market Size, by Indication, 2025 vs 2032 (%)
  • FIGURE 9. Global Interatrial Shunt Device Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Interatrial Shunt Device Market Size, by Procedure Type, 2025 vs 2032 (%)
  • FIGURE 11. Global Interatrial Shunt Device Market Size, by Procedure Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Interatrial Shunt Device Market Size, by Patient Age Group, 2025 vs 2032 (%)
  • FIGURE 13. Global Interatrial Shunt Device Market Size, by Patient Age Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Interatrial Shunt Device Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Interatrial Shunt Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Interatrial Shunt Device Market Size, by Distribution Channel, 2025 vs 2032 (%)
  • FIGURE 17. Global Interatrial Shunt Device Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Interatrial Shunt Device Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Interatrial Shunt Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Interatrial Shunt Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Interatrial Shunt Device Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Interatrial Shunt Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Interatrial Shunt Device Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Interatrial Shunt Device Market Segmentation & Coverage
  • TABLE 2. Global Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Permanent Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Permanent Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Permanent Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Retrievable Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Retrievable Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Retrievable Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 11. Global Heart Failure With Preserved Ejection Fraction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Heart Failure With Preserved Ejection Fraction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Heart Failure With Preserved Ejection Fraction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Heart Failure With Reduced Ejection Fraction Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Heart Failure With Reduced Ejection Fraction Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Heart Failure With Reduced Ejection Fraction Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 18. Global Surgical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 19. Global Surgical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 20. Global Surgical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 21. Global Transcatheter Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 22. Global Transcatheter Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 23. Global Transcatheter Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 24. Global Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 25. Global Adults Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Adults Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Adults Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Geriatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Geriatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Geriatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Pediatric Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Pediatric Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Pediatric Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 35. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 36. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 37. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 38. Global Cardiac Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 39. Global Cardiac Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 40. Global Cardiac Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 41. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 45. Global Direct Tender Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Direct Tender Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Direct Tender Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Distributor Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Distributor Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Distributor Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global National Distributor Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global National Distributor Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global National Distributor Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Regional Distributor Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Regional Distributor Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Regional Distributor Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global E-Commerce Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global E-Commerce Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global E-Commerce Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Asia-Pacific Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Asia-Pacific Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 63. Asia-Pacific Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 64. Asia-Pacific Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 65. Asia-Pacific Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 66. Asia-Pacific Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 67. Asia-Pacific Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 68. Asia-Pacific Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 69. North America Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. North America Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 71. North America Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 72. North America Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 73. North America Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 74. North America Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 75. North America Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 76. North America Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 77. Latin America Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 78. Latin America Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 79. Latin America Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 80. Latin America Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 81. Latin America Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 82. Latin America Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 83. Latin America Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 84. Latin America Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 85. Europe Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 86. Europe Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 87. Europe Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 88. Europe Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 89. Europe Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 90. Europe Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 91. Europe Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 92. Europe Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 93. Middle East Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Middle East Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 95. Middle East Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 96. Middle East Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 97. Middle East Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 98. Middle East Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 99. Middle East Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 100. Middle East Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 101. Africa Interatrial Shunt Device Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 102. Africa Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 103. Africa Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 104. Africa Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 105. Africa Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 106. Africa Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 107. Africa Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 108. Africa Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 109. Global Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. ASEAN Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. ASEAN Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 112. ASEAN Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 113. ASEAN Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 114. ASEAN Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 115. ASEAN Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. ASEAN Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 117. ASEAN Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 118. GCC Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 119. GCC Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 120. GCC Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 121. GCC Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 122. GCC Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 123. GCC Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 124. GCC Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 125. GCC Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 126. European Union Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. European Union Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 128. European Union Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 129. European Union Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 130. European Union Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 131. European Union Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 132. European Union Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 133. European Union Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 134. BRICS Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. BRICS Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 136. BRICS Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 137. BRICS Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 138. BRICS Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 139. BRICS Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 140. BRICS Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 141. BRICS Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 142. G7 Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 143. G7 Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 144. G7 Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 145. G7 Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 146. G7 Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 147. G7 Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. G7 Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 149. G7 Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 150. NATO Interatrial Shunt Device Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. NATO Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 152. NATO Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 153. NATO Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 154. NATO Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 155. NATO Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 156. NATO Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 157. NATO Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 158. Global Interatrial Shunt Device Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 159. United States Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 160. United States Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 161. United States Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 162. United States Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 163. United States Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 164. United States Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 165. United States Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 166. United States Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 167. Canada Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 168. Canada Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 169. Canada Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 170. Canada Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 171. Canada Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 172. Canada Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 173. Canada Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 174. Canada Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 175. Mexico Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 176. Mexico Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 177. Mexico Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 178. Mexico Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 179. Mexico Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 180. Mexico Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 181. Mexico Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 182. Mexico Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 183. Brazil Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 184. Brazil Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 185. Brazil Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 186. Brazil Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 187. Brazil Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 188. Brazil Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. Brazil Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 190. Brazil Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 191. United Kingdom Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 192. United Kingdom Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 193. United Kingdom Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 194. United Kingdom Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 195. United Kingdom Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 196. United Kingdom Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 197. United Kingdom Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 198. United Kingdom Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 199. Germany Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 200. Germany Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 201. Germany Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 202. Germany Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 203. Germany Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 204. Germany Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 205. Germany Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 206. Germany Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 207. France Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 208. France Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 209. France Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 210. France Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 211. France Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 212. France Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 213. France Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 214. France Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 215. Russia Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 216. Russia Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 217. Russia Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 218. Russia Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 219. Russia Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 220. Russia Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 221. Russia Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 222. Russia Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 223. Italy Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 224. Italy Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 225. Italy Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 226. Italy Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 227. Italy Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 228. Italy Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 229. Italy Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 230. Italy Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 231. Spain Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 232. Spain Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 233. Spain Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 234. Spain Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 235. Spain Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 236. Spain Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 237. Spain Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 238. Spain Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 239. China Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 240. China Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 241. China Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 242. China Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 243. China Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 244. China Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 245. China Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 246. China Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 247. India Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 248. India Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 249. India Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 250. India Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 251. India Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 252. India Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 253. India Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 254. India Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 255. Japan Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 256. Japan Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 257. Japan Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 258. Japan Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 259. Japan Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 260. Japan Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. Japan Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 262. Japan Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 263. Australia Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 264. Australia Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 265. Australia Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 266. Australia Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 267. Australia Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 268. Australia Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 269. Australia Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 270. Australia Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 271. South Korea Interatrial Shunt Device Market Size, 2017-2032 (USD Million)
  • TABLE 272. South Korea Interatrial Shunt Device Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 273. South Korea Interatrial Shunt Device Market Size, by Indication, 2017-2032 (USD Million)
  • TABLE 274. South Korea Interatrial Shunt Device Market Size, by Procedure Type, 2017-2032 (USD Million)
  • TABLE 275. South Korea Interatrial Shunt Device Market Size, by Patient Age Group, 2017-2032 (USD Million)
  • TABLE 276. South Korea Interatrial Shunt Device Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 277. South Korea Interatrial Shunt Device Market Size, by Distribution Channel, 2017-2032 (USD Million)
  • TABLE 278. South Korea Interatrial Shunt Device Market Size, by Distributor, 2017-2032 (USD Million)
  • TABLE 279. Global Interatrial Shunt Device Market Share, by Key Player, 2025
  • TABLE 280. Global Interatrial Shunt Device Market, Key Experts